- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jerusalem Pharmaceuticals Co Ltd (JPH)
Jerusalem Pharmaceuticals Co Ltd stock price live, this page displays PEX JPH stock exchange data. View the JPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jerusalem Pharmaceuticals Co Ltd real time stock price chart below.
What Is the Jerusalem Pharmaceuticals Co Ltd Stock Price Today?
The Jerusalem Pharmaceuticals Co Ltd stock price today is 3.880.
What Is the Stock Symbol for Jerusalem Pharmaceuticals Co Ltd?
The stock symbol for Jerusalem Pharmaceuticals Co Ltd is "JPH."
What Stock Exchange Does Jerusalem Pharmaceuticals Co Ltd Trade On?
Jerusalem Pharmaceuticals Co Ltd is listed and trades on the Ramallah stock exchange.
Is Jerusalem Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether Jerusalem Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JPH quote. (ISIN: PS2016112695)
What Is the Jerusalem Pharmaceuticals Co Ltd Stock Price Today?
The Jerusalem Pharmaceuticals Co Ltd stock price today is 3.880.
What Is the Stock Symbol for Jerusalem Pharmaceuticals Co Ltd?
The stock symbol for Jerusalem Pharmaceuticals Co Ltd is "JPH."
What Stock Exchange Does Jerusalem Pharmaceuticals Co Ltd Trade On?
Jerusalem Pharmaceuticals Co Ltd is listed and trades on the Ramallah stock exchange.
Is Jerusalem Pharmaceuticals Co Ltd a Good Stock to Buy?
Determining whether Jerusalem Pharmaceuticals Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JPH quote. (ISIN: PS2016112695)
Ramallah
Currency in USD
3.880
+0.180(+4.86%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.600
3.880
52 wk Range
1.900
4.000
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
3.6003.880
52 wk Range
1.9004.000
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.01%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.01%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
JPH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Earnings
Latest Release
May 14, 2026
EPS / Forecast
0.12 / --
Revenue / Forecast
11.21M / --
Compare JPH to Peers and Sector
Metrics to compare | JPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.7x | 13.3x | −0.4x | |
PEG Ratio | 0.28 | −0.74 | 0.00 | |
Price/Book | 1.6x | 2.0x | 2.6x | |
Price / LTM Sales | 2.8x | 2.1x | 3.0x | |
Upside (Analyst Target) | - | 17.5% | 51.9% | |
Fair Value Upside | Unlock | 3.6% | 9.1% | Unlock |
Jerusalem Pharmaceuticals Co. Ltd., together with its subsidiaries, manufactures and sells a range of human medicines and medical supplies in Palestine, the Middle East, North Africa, and internationally. It operates through two segments: Pharmaceutical Sales and All Other Segments. The company offers over the counter, prescription pharmaceutical, and nutritional supplement products in various dosage forms, including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, and ointments, as well as ear and nose drops and solutions. It also provides medical devices; detergents; cosmetic; personal hygiene; veterinary; and agricultural products, as well as engages in printing services. The company’s products are used in cardiovascular, gastrointestinal and metabolic, respiratory, analgesic and musculoskeletal, dermatology, central nervous system, anti-infective, and oncology therapeutic areas. It operates in Jordan, Algeria, the Kingdom of Saudi Arabia, the United Arab Emirates, Lebanon, Iraq, Qatar, Kuwait, Bahrain, Oman, Yemen, Sudan, Ethiopia, Ivory Coast, Libya, Belarus, and other countries. The company was founded in 1969 and is headquartered in Ramallah, Palestinian Authority.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Jerusalem Pharma (JPH) Stock Price Today?
The Jerusalem Pharma stock price today is 3.880 USD.
What Stock Exchange Does Jerusalem Pharma Trade On?
Jerusalem Pharma is listed and trades on the Ramallah Stock Exchange.
What Is the Stock Symbol for Jerusalem Pharma?
The stock symbol for Jerusalem Pharma is "JPH."
Does Jerusalem Pharma Pay Dividends? What’s The Current Dividend Yield?
The Jerusalem Pharma dividend yield is 4.01%.
What Is the Jerusalem Pharma Market Cap?
As of today, Jerusalem Pharma market cap is 139.680M USD.
What Is Jerusalem Pharma's Earnings Per Share (TTM)?
The Jerusalem Pharma EPS (TTM) is 0.284.
From a Technical Analysis Perspective, Is JPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Jerusalem Pharma Stock Split?
Jerusalem Pharma has split 4 times.
How Many Employees Does Jerusalem Pharma Have?
Jerusalem Pharma has 595 employees.
What is the current trading status of Jerusalem Pharma (JPH)?
As of Jul 10, 2026, Jerusalem Pharma (JPH) is trading at a price of 3.880 USD, with a previous close of 3.700 USD. The stock has fluctuated within a day range of 3.600 USD to 3.880 USD, while its 52-week range spans from 1.900 USD to 4.000 USD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.